Suggestions on the use of statistical methodologies in studies of the European Group for Blood and Marrow Transplantation

Bone Marrow Transplantation

Volumn 48, Issue SUPPL.1, 2013, Pages

  Iacobelli, Simona ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

competing risks; statistical guidelines; statistical methods; stem cell transplantation research; survival analysis

Indexed keywords

ACCURACY; ARTICLE; CLINICAL STUDY; DISEASE FREE SURVIVAL; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MEDICAL RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROBABILITY; PROGRESSION FREE SURVIVAL; RECURRENCE FREE SURVIVAL; REGRESSION ANALYSIS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STUDY DESIGN; SURVIVAL RATE;

CLINICAL TRIALS AS TOPIC; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; REGRESSION ANALYSIS;

EID: 84875201737     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2012.282     Document Type: Article

References (50)

1. Bauer P. Multiple testing in clinical trials. Stat Med 1991; 10: 871-890.
2. Marubini E, Valsecchi MG. Analysing Survival Data from Clinical Trials and Observational Studies.Wiley: New York, 2004.
3. Beyersmann J, Gastmeier P, Wolkewitz M, Schumacher M. An easy mathematical proof showed that time-dependent bias inevitably leads to biased effect estimation. J Clin Epidemiol 2008; 61: 1216-1221.
4. Simon R, Makuch RW. A non-parametric graphical representation of the relationship between survival and the occurrence of an event: application to responder versus nonresponder bias. Stat Med 1984; 3: 35-44. (Pubitemid 14142275)
5. Putter H, Fiocco M, Geskus RB. Tutorial in biostatistics: competing risks and multi-state models. Stat Med 2007; 26: 2389-2430. (Pubitemid 46730255)
6. Keiding N, Klein JP, Horowitz MM. Multi-state models and outcome prediction in bone marrow transplantation. Stat Med 2001; 20: 1871-1885. (Pubitemid 32590959)
7. Iacobelli S, Apperley J, Morris C. Assessment of the role of timing of second transplantation in multiple myeloma by multistate modeling. Exp Hematol 2008, 1567-1571.
8. Iacobelli S. Statistical modeling of complex disease histories in Bone Marrow Transplant. Guidelines for proper use and interpretation of the Cox model for the European Group for Blood and Marrow Transplantation. 2004. Available from the EBMT website www.ebmt.org.
9. van Houwelingen HC, Putter H. Dynamic predicting by landmarking as an alternative for multi-state modeling: an application to acute lymphoid leukemia data. Lifetime Data Anal 2008; 14: 447-463.
10. Klein JP, Rizzo JD, Zhang MJ, Keiding N. Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part 1: Unadjusted analysis. Bone Marrow Transplant 2001; 28: 909-915. (Pubitemid 33130231)
11. Klein JP, Keiding N, Shu YY, Szydlo RM, Goldman JM. Summary curves for patients transplanted for chronic myeloid leukaemia salvaged by a donor lymphocyte infusion: the current leukaemia-free survival curve. Br J Haematol 2000; 109: 148-152. (Pubitemid 30340591)
12. Liu, Logan, Klein JP. Inference for current leukemia free survival. Lifetime Data Anal 2008; 14: 432-446.
13. Klein JP, Logan B, Harhoff M, Andersen PK. Analyzing survival curves at a fixed point in time. Stat Med 2007; 26: 4505-4519. (Pubitemid 47534694)
14. Logan B, Klein JP, Zhang MJ. Comparing treatments in the presence of crossing survival curves: an application to Bone Marrow Transplantation. Biometrics 2008; 64: 733-740.
15. Corbiere F, Joly P. A SAS macro for parametric and semiparametric mixture cure models. Comput Meth Programs Biomed 2007; 85: 173-180. (Pubitemid 46108129)
16. Sposto R. Cure model analysis in cancer: an application to data from the Children's Cancer Group. Stat Med 2002; 21: 293-312. (Pubitemid 34048694)
17. Klein JP, Moeschberger ML. Survival Analysis. Techniques for Censored and Truncated Data. 2nd edn. Springer: New York, 2003.
18. Therneau TM, Grambsch PM. Modeling Survival Data: Extending the Cox Model. Springer: Berlin, 2000.
19. Hosmer D, Lemeshow S, May S. Applied Survival Analysis: Regression Modeling of Time to Event Data, 2nd edn. Wiley: New York, 2008.
20. Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representation of old estimators. Stat Med 1999; 18: 695-706. (Pubitemid 29126745)
21. Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988; 16: 1141-1154.
22. Fine JP, Gray RJ. A proportional hazard model for the subdistribution of a competing risk. JASA 1999; 94: 496-509.
23. Klein JP, Andersen PK. Regression modeling of competing risks data based on pseudo-values of the cumulative incidence function. Biometrics 2005; 61: 223-229. (Pubitemid 40380983)
24. Dignam JJ, Kocherginsky MN. Choice and interpretation of statistical tests used when competing risks are present. J Clin Oncol 2008; 26: 4027-4034.
25. Logan BR, Zhang MJ, Klein JP. Regression models for hazard rates versus cumulative incidence probabilities in haematopoietic cell transplantation data. Biol Bone Marrow Transplant 2006; 12 (Suppl 1): 107-112. (Pubitemid 43034129)
26. Latouche A. Improving statistical analysis of prospective clinical trials in stem cell transplantation. An inventory of new approaches in survival analysis'. Technical Report of the CLINT-Establishment of infrastructure to support International Prospective Clinical Trials in Stem Cell Transplantation, 2010. Available from COBRA Preprint Series, Art. 70. http://biostats.bepress. com/cobra/ps/art70 .
27. Klein JP. Modeling competing risks in cancer studies. Stat Med 2006; 25: 1015-1034. (Pubitemid 43337987)
28. Harrell Jr FE. Regression Modeling Strategies. Springer: Berlin, 2001.
29. Schemper M, Smith TL. A note on quantifying follow-up in studies of failure time. Control Clin Trials 1996; 17: 343-346. (Pubitemid 26342716)
30. Klein JP, Rizzo JD, Zhang MJ, Keiding N. Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part 2: Regression modelling. Bone Marrow Transplantation 2001; 28: 1001-1011. (Pubitemid 34030645)
31. Andersen PK, Klein JP, Zhang MJ. Testing for centre effects in multi-centre survival studies: a Monte Carlo comparison of fixed and random effects tests. Stat Med 1999; 18: 1489-1500. (Pubitemid 29296604)
32. Glidden DV, Vittingho E. Modeling clustered survival data from multicentre clinical trials. Stat Med 2004; 23: 369-388. (Pubitemid 38180794)
33. Yamaguchi T, Ohashi Y, Matsuyama Y. Proportional hazards models with random effects to examine centre effects in multicentre cancer clinical trials. Stat Meth Med Res 2002; 11: 221-236. (Pubitemid 34678689)
34. Royston P, Altman DG, Sauerbrei W. Dichotomizing continuous predictors in multiple regression: a bad idea. Stat Med 2006; 25: 127-141. (Pubitemid 43136953)
35. Statistical Methods in Medical Research 1994 Vol. 3 (Five papers on frailty models for heterogeneity and dependence).
36. Scheike TH, Zhang MJ. Extensions and applications of the Cox-Aalen survival model. Biometrics 2003; 59: 1036-1045. (Pubitemid 38021233)
37. van Houwelingen HC. Dynamic prediction by landmarking in event history analysis. Scand J Stat 2007; 34: 70-85.
38. D'Agostino Jr RB. Tutorial in biostatistics. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998; 17: 2265-2281. (Pubitemid 28466823)
39. Lunceford JK, Davidian M. Stratification and weighting via the propensity score in estimation of causal treatment effects: a comparative study. Stat Med 2004; 23: 2937-2960. (Pubitemid 39200133)
40. Senn S, Graf E, Caputo A. Stratification for the propensity score compared with linear regression techniques to assess the effect of treatment or exposure. Stat Med 2007; 26: 5529-5544. (Pubitemid 351193579)
41. Wei LJ, Glidden DV. An overview of statistical methods for multiple failure time data in clinical trials. Stat Med 1997; 16: 833-839.
42. Cole SR, Hernán MA. Adjusted survival curves with inverse probability weights. Comput Meth Prog Biomed 2004; 75: 45-49. (Pubitemid 38648876)
43. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. 2nd edn. Wiley: New York, 2002.
44. Fine JP, Jiang H, Chappell R. On semi-competing risks data. Biometrika. 2001; 88: 907-919. (Pubitemid 33771541)
45. Scheike TH, Zhang MJ. Flexible competing risks regression modeling and goodness-of-fit. Lifetime Data Anal 2008; 14: 464-483.
46. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effect. Biometrika 1983; 70: 41-55.
47. Scrucca L, Santucci A, Aversa F. Competing risk analysis using R: an easy guide for clinicians. Bone Marrow Transplant 2007; 40: 381-387. (Pubitemid 47202424)
48. Scrucca L, Santucci A, Aversa F. Regression modeling of competing risk using R: an in depth guide for clinicians. Bone Marrow Transplant 2010; 45: 1388-1395.
49. de Wreede L, Fiocco M, Putter H. mstate. An R package for the analysis of competing risks and multi-state models. J Stat Softw 2011; 38: 1-30.
50. de Wreede L, Fiocco M, Putter H. The mstate package for estimation and prediction in non-and semi-parametric multistate and competing risks models. Comput Meth Prog Biomed 2010; 99: 261-274.